Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
We will email you instructions to reset your
J. Schmitt1, M.L. Scott1, E. Ospelt2, O. Ebekozien2, M.P. Gallagher3, P. Prahalad4, G. Nelson5, M. Kamboj6, C. Demeterco-Berggren7
1University of Alabama at Birmingham, Pediatric Endocrinology, Birmingham, USA, 2T1D Exchange, Quality Improvement and Population Health, Boston, USA, 3NYU Langone Health, Pediatric Endocrinology, New York, USA, 4Lucile Packard Children’s Hospital Stanford, Pediatric Endocrinology, Palo Alto, USA, 5Le Bonheur Children’s Hospital, University of Tennessee, Pediatric Endocrinology, Memphis, USA, 6Nationwide Children’s Hospital, Pediatric Endocrinology, Columbus, USA, 7Rady Children’s Hospital, Pediatric Endocrinology, San Diego, USA
Introduction: The use of smart insulin pens has the potential to improve glucose stability, medication adherence, glycemic management, time in range, dose accuracy, quality of visits, and virtual care opportunities for patients living with diabetes.
Objectives: The purpose of this study was to identify facilitators to smart insulin pen use by assessing provider and care team perceptions.
This site uses Akismet to reduce spam. Learn how your comment data is processed.